Emerging Markets to Lead Biosimilars Market Growth, Global Market to Reach $53 Billion by 2025 – Market Report (2018-2025) by Industry Experts, Inc.
Notice: A non well formed numeric value encountered in /home/o54g1b2ba3v6/public_html/_news/includes/site.funct.php on line 4
Thursday 09 May 2019
Industry Experts, Inc. unveiled the new 2019 version of its global market report on Biosimilars. The new version of the report entitled "Global Biosimilars Market – Products, Applications and Regulations" reveals that the global market for Biosimilar G-CSF is poised to post the fastest similar period CAGR of 33% and reach a projected US$7.3 billion by 2025.
Cost effectiveness, increasing geriatric population, rising incidences and prevalence of chronic ailments such as Cancer, Autoimmune Disorders and Diabetes and supportive government regulations and guidelines are some of the factors fueling the biosimilars market. Furthermore, the growth of the biosimilars market is retarded due to insufficient regulatory guideline, expensive research and development procedures and preference of patented products by the patients, etc. Patent expiry of most of the monoclonal antibody based biologics drives the biosimilar monoclonal antibody market. Oncology biosimilar market leads the biosimilars market and is primarily driven by the rising prevalence and incidence of cancer and patent expiry of the expensive biologics.
Monoclonal Antibodies constitute the single largest product type in the global Biosimilars market, demand for which is estimated at US$4.4 billion in 2018 and is projected to reach US$28.8 billion by 2025. The overall Biosimilars market in 2019 is expected to reach US$10.4 billion.
The report reviews, analyzes and projects the Biosimilars market
for the period 2016-2025 in terms of USD. The market for Biosimilar product types analyzed in this study comprises Monoclonal Antibodies, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Insulin and Other product types (including Interferons, Follitropins, Recombinant Proteins etc.). The report also encompasses the market analysis for Therapeutic Areas consisting Oncology, Autoimmune Disorders, Blood Disorders, Growth Hormone Deficiency and Other therapeutic areas (including Chronic Diseases, Infectious Diseases, Cardiovascular Disorders etc.).
Global Biosimilars market is segmented into four major geographic regions, for the purpose of this study, namely Europe, North America, Asia-Pacific and Rest of World. These regional markets further analyzed for 14 independent countries across Europe – Germany, the United Kingdom, France, Spain and Italy; North America – the United States, Canada and Mexico; Asia-Pacific – China, India, Japan and South Korea; and Rest of World – Brazil and Israel.
This 364 page Biosimilars global market report includes 223 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and major therapeutic/application area. This report includes the brief business profiles of 26 key global players and 42 major players across North America – 10; Europe – 8; Asia-Pacific – 22; and Rest of World – 2. The report also provides the listing of the companies engaged in research & development, manufacturing and supply of Biosimilars. The global list of companies covers addresses, contact numbers and the website addresses of 151 companies.
California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.
For more details, please visit https://industry-experts.com/verticals/biotechnology/global-biosimilars-market-products-applications-and-regulations